Value-Based Agreements – Are We Going to See More or Less of Them?
Sydney Otomancek2022-01-05T11:26:30-05:00Value, Evidence, Access|
Mike Pace, MBA, Pierre Etienne, MD, and Clifton Chow give an insightful and practical webinar on one of the most important areas in pharmaceutical value and market access.
Featured Webinars
A Ready-to-Analyze High-Plex Spatial Signature Development Workflow for Cancer Immunotherapy
Tuesday, November 28, 2023
Sponsors: Akoya Biosciences, OracleBio
Partner: Scientist.com
More Than What You Eat: The Regulation of Metabolic Health and Aging by Diet Composition and Activity
Tuesday, November 28, 2023
Sponsor: Columbus Instruments
Advancing Disease Modeling for Drug Discovery by Modulating iPSCs with CRISPR and Neuronal Differentiation
Wednesday, November 29, 2023
Sponsors: Synthego, BrainXell Inc.
Partner: Scientist.com
Advertisement
Latest News & Resources
The Sweet Truth: Unwrapping the Science of Semaglutide
August 9, 2023
Taurine: An Unexpected Anti-Aging Ally
July 18, 2023
Content Categories
Aging
Analytical Sciences
Animal Behavioral Neuroscience
Auditory Sciences
Cancer & Oncology Research
Cardiovascular
Cell & Molecular Biology
Clinical Research
Drug Discovery & Development
Education & Teaching
Epidemiology & Infectious Disease
General Biology
Genetics & Genomics
Human Physiology
Industry & Career
Lab Animal Sciences
Materials Science
Metabolic Function
Microbiology & Immunology
Microscopy
Muscle Physiology & Function
Neuroscience
Obesity
Pharmacology
Preclinical Imaging
Renal Physiology
Respiratory Science
Sports Science
Toxicology
Value, Evidence, Access
Vascular Biology
Vision Research